Close
Leave blank for all. Otherwise, the first selected term will be the default instead of "Any".

Federal Register Notice of 2010 TIP Competition: NIST issues notice of 2010 TIP competition

Mar 10 2016

Amendment to Federal Register Notice: NIST issues amendments 2010 TIP competition

Mar 10 2016
NIST clarifies that device development is not a focus of 2010 TIP competition.

Biodefense: 2010 National Security Strategy

Mar 10 2016
May 2010 National Security Strategy from the White House

Biodefense: 2009 National Strategy for Countering Biological Threats

Mar 10 2016
White House National Security Council - November 2009 National Strategy for Countering Biological Threats

Promoting Health and Preventing Disease: Childhood and Adult Vaccine Updates and Recommendations

Mar 10 2016
Centers for Disease Control & Prevention, Clinician Outreach and Community Activity (COCA) Conference Call July 27, 2010.

Technological Innovation Program (TIP): NIST proposes new program support, promote, and accelerate innovation in the United States through high-risk, high-reward research in areas of critical national need.

Mar 10 2016
BIO applauds NIST on implementation of TIP program and urges that personalized medicine be included as an area of "critical national need"

Cures Acceleration Network: Patient Group Letter

Mar 10 2016
The letter, signed by approximately 85 patient groups, requests appropriation for CAN in FY2011

Cures Acceleration Network: BIO Strongly Supports the CAN Program

Mar 10 2016
Implementation of CAN will help NIH-funded researchers bridge the precarious gap between basic research and the eventual development of new cures and treatments for many of the diseases we face today.

Pilot Circuit Breaker Proposal: SEC issues proposal on pilot circuit breaker program to combat abusive short selling

Mar 10 2016
BIO commends the SEC on its pilot circuit breaker proposal and urges the use of biotech companies in such proposal

Sarbanes-Oxley in Financial Services Compromise: Sarbanes-Oxley 404(b) Legislative Text in the Wall Street Reform and Consumer Protection Act of 2009

Mar 10 2016
BIO advocated for a provision in financial services reform that would ease regulatory burdens for small public biotechnology companies.